Diala Alatassi, MD, FACP Medical Reviewer Diala Alatassi, MD, is a board-certified obesity medicine specialist who is committed to providing comprehensive, compassionate, and personalized care
[2] Any patient presenting with suspected semaglutide overdose should undergo clinical assessment including vital signs, hydration status, blood glucose monitoring, and consideration of serum electrolytes and renal function
Tirzepatide (branded as Mounjaro) is FDA-approved and targets GLP-1 and GIP receptors
It is designed for self-use at home, resembling a pen, making it portable and easy to carry for on-the-go use
renal function should be monitored if persistent vomiting or diarrhoea occurs Individuals with eating disorders or a history of disordered eating : Significant appetite suppression may exacerbate underlying psychological relationships with food Healthcare professionals should conduct a thorough medical history and risk assessment before enrolling patients in trials or, in future, prescribing retatrutide
All require a prescription